Download PDF

Other users also viewed these articles

BILE ACID PROFILES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE Maria Ayala Valverde; Nancy Solis; Francisca Allendes; Francisco Barrera; Jorge Arnold Alvarez; Cristina Alonso; Juan Pablo Arab; Daniel Cabrera; Luis Antonio Diaz; Ibon Martinez-Arranz; Marco Arrese;
Ann Hepatol. 2025;30 Supl 2:
OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles MARIA AYALA VALVERDE; Jorge Arnold Alvarez; Gustavo Ayares; Francisco Barrera; Daniel Cabrera; Luis Antonio Diaz; Juan Pablo Arab; Ibon Martinez-Arranz; Cristina Alonso; Jesús M. Bañales; Marco Arrese;
Ann Hepatol. 2024;29 Supl 3:
O2- CHARACTERIZATION OF STEATOTIC LIVER DISEASE AND THE ROLE OF GENETIC BACKGROUND IN LATIN AMERICA LUIS ANTONIO DÍAZ PIGA; Carolina Aguilera; Gustavo Ayares; Francisco Idalsoaga; Mauricio Pizarro; Fernando Javier Barreyro; Sebastián Marciano; Jorge Martínez Morales; Cristiane Villela-Nogueira; Nathalie Leite; Claudia Alves Couto; Rafael Theodoro; Mísia Joyner de Sousa Dias Monteiro; Mario G. Pessoa; Mario Reis Alvares-da-Silva; Fátima Higuera de la Tijera; Adelina Lozano; Pedro Montes; Graciela Castro-Narro; Constanza D. Sabate; Manuel Mendizabal; Francisco Barrera; Daniel Cabrera; Mazen Noureddin; Naim Alkhouri; Winston Dunn; Zobair Younossi; Jeffrey V. Lazarus; Rohit Loomba; Claudia Pinto Marques Souza de Oliveira; Adrian Gadano; Marco Arrese; Juan Pablo Arab;
Ann Hepatol. 2024;29 Supl 3: